Literature DB >> 19229272

The efficacy and safety of posterior pole buckles in the control of progressive high myopia.

B Ward1, E P Tarutta, M J Mayer.   

Abstract

PURPOSE: Degenerative myopia is a significant cause of vision loss; yet there is no accepted way of controlling its causative phenotype--progressive high axial myopia. Scleral reinforcement, introduced over 50 years ago, was discredited as a useful technique. This 5-year 'proof of concept' study examines buckling of the posterior pole for myopia control and follows the course of untreated fellow eyes.
METHOD: A total of 59 adult eyes, with myopic refractive corrections ranging from -9 to -22 D and axial lengths from 27.8 to 34.6 mm, were studied. A 1-cm-wide flexible buckle of donor sclera was positioned over the posterior pole and secured, under positive tension, to the anterior globe. The eyes were monitored for 5 years, as were unsupported fellow eyes. The axial lengths, visual acuities, and optical coherence tomography macular scans were collected and all complications were noted.
RESULTS: Over 5 years, axial length control was achieved by scleral buckling, whereas axial extension progressed in the untreated group. No serious complication occurred and no eye lost visual acuity from the procedure. Temporary intra-ocular pressure elevation, small choroidal effusions, and variable periods of abduction limitation occurred after surgery. In one case of tractional myopic macular schisis, a full correction was achieved by buckling and visual acuity improved.

Entities:  

Mesh:

Year:  2009        PMID: 19229272     DOI: 10.1038/eye.2008.433

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  21 in total

Review 1.  Scleral Mechanisms Underlying Ocular Growth and Myopia.

Authors:  Ravi Metlapally; Christine F Wildsoet
Journal:  Prog Mol Biol Transl Sci       Date:  2015-06-12       Impact factor: 3.622

2.  Posterior sclera reinforcement and phakic intraocular lens implantation for highly myopic amblyopia in children: a 3-year follow-up.

Authors:  S-Q Zhu; Q-M Wang; A-Q Xue; L-Y Zheng; Y-F Su; A-Y Yu
Journal:  Eye (Lond)       Date:  2014-08-15       Impact factor: 3.775

3.  Posterior scleral reinforcement for the treatment of pathological myopia.

Authors:  Xiu-Juan Li; Xiao-Peng Yang; Qiu-Ming Li; Yu-Ying Wang; Yuan Wang; Xiao-Bei Lyu; Heng Jia
Journal:  Int J Ophthalmol       Date:  2016-04-18       Impact factor: 1.779

Review 4.  Concise Review: Using Stem Cells to Prevent the Progression of Myopia-A Concept.

Authors:  Miroslaw Janowski; Jeff W M Bulte; James T Handa; David Rini; Piotr Walczak
Journal:  Stem Cells       Date:  2015-05-12       Impact factor: 6.277

Review 5.  Recent trends in the management of maculopathy secondary to pathological myopia.

Authors:  D Mitry; H Zambarakji
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-12-13       Impact factor: 3.117

6.  The efficacy and safety of modified Snyder-Thompson posterior scleral reinforcement in extensive high myopia of Chinese children.

Authors:  Minjie Chen; Jinhui Dai; Renyuan Chu; Yifeng Qian
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-08-02       Impact factor: 3.117

7.  Posterior scleral reinforcement combined with patching therapy for pre-school children with unilateral high myopia.

Authors:  Zhao-Meng Shen; Zhen-Yong Zhang; Lin-Yi Zhang; Zhi-Guo Li; Ren-Yuan Chu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-02-19       Impact factor: 3.117

8.  Long-term follow-up of vitrectomy in patients with pathologic myopic foveoschisis.

Authors:  Ting Zhang; Ying Zhu; Chun-Hui Jiang; Ge-Zhi Xu
Journal:  Int J Ophthalmol       Date:  2017-02-18       Impact factor: 1.779

9.  Scleral reinforcement through host tissue integration with biomimetic enzymatically degradable semi-interpenetrating polymer network.

Authors:  James Su; Samuel T Wall; Kevin E Healy; Christine F Wildsoet
Journal:  Tissue Eng Part A       Date:  2010-03       Impact factor: 3.845

Review 10.  Myopic Traction Maculopathy: Diagnostic and Management Strategies.

Authors:  Rino Frisina; Irene Gius; Michele Palmieri; Alessandro Finzi; Luigi Tozzi; Barbara Parolini
Journal:  Clin Ophthalmol       Date:  2020-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.